Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
8
×
fda
8
×
life sciences
national blog main
roche
8
×
biotech
boston blog main
boston top stories
national top stories
clinical trials
san francisco blog main
investing
san francisco top stories
boston
cancer
new york blog main
san diego blog main
san diego top stories
startups
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
takeda pharmaceutical
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
biogen
crispr-cas9
What
drug
roche
roundup
ahead
asco
bio
cancer
days
devices
digital
fda
medicines
pay
team
acquire
agreed
alliance
ambien
american
analytics
annual
approval
attendees
attention
awards
big
billion
biofourmis
biotech
blueprint
branded
bristol
broad
buy
calls
camp’s
candidate
cash
caught
causing
Language
unset
Current search:
fda
×
deals
×
roche
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Meet the Xconomy Awards San Diego Digital Trailblazer Finalists
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More